GlassScriptPhysician profile
Ronald M Pucillo
NPI 1548263106
$12,846.11
in general payments reported to CMS, 2019-2025
72 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2020: $2,096 · 2021: $1,849 · 2022: $1,888 · 2023: $1,497 · 2024: $1,838 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,050 · Education: $16.90 · Entertainment: $16.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,050.33 |
| Education | $16.90 |
| Entertainment | $16.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,101.96 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Abbvie INC. | $1,082.74 | 2019-2025 | |
| Novo Nordisk INC | $1,069.84 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $912.74 | 2019-2025 | Repatha, Otezla, Evenity |
| Amarin Pharma, INC. | $738.53 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $653.41 | 2019-2025 | Airsupra, Breztri |
| Lilly USA, LLC | $597.93 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Pfizer INC. | $486.30 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $394.05 | 2019-2024 | Verquvo, Belsomra, Vaxneuvance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $362.76 | 2019-2024 | Cycloset, Xifaxan |
| Glaxosmithkline, LLC. | $359.51 | 2019-2024 | Shingrix, Arexvy, Fluarix Quadrivalent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $338.29 | 2019-2025 | Jardiance |
| Renalytix Ai, INC. | $326.09 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Bayer Healthcare Pharmaceuticals INC. | $319.82 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $275.84 | 2019-2023 | Xarelto |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $266.23 | 2019-2020 | |
| Dexcom, INC. | $240.54 | 2020-2025 | Dexcom G6 Transmitter |
| Stryker Corporation | $222.09 | 2022-2025 | Clottriever Bold Catheter |
| Avvisto Therapeutics, LLC | $203.82 | 2025 | Cycloset |
| Horizon Therapeutics Plc | $191.67 | 2019-2023 | Krystexxa |
| Exact Sciences Corporation | $165.81 | 2023-2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $164.83 | 2019-2023 | Trintellix |
| Novartis Pharmaceuticals Corporation | $161.26 | 2020-2025 | |
| Corium, LLC | $161.07 | 2021-2025 | Azstarys |
| Endo Pharmaceuticals INC. | $140.01 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $120.61 | 2019-2022 | |
| Ibsa Pharma INC. | $120.09 | 2020-2025 | Licart, Tirosint, Flector |
| Axsome Therapeutics, INC. | $110.25 | 2025 | Symbravo, Auvelity |
| Eisai INC. | $109.95 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $102.81 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $102.28 | 2019-2023 | Seglentis |
| Sanofi Pasteur INC. | $95.83 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $91.39 | 2019-2022 | |
| Astellas Pharma US INC | $84.00 | 2020-2024 | Veozah |
| Redhill Biopharma INC. | $72.04 | 2020-2021 | |
| Antares Pharma, INC. | $71.21 | 2021-2023 | Xyosted, Tlando, Nocdurna |
| Idorsia Pharmaceuticals US INC | $54.60 | 2022-2023 | Quviviq |
| Jazz Pharmaceuticals INC. | $47.07 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $45.89 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $42.71 | 2022 | |
| Esperion Therapeutics, INC. | $42.39 | 2020-2022 | |
| Medtronic, INC. | $41.75 | 2023-2024 | Intellis Adaptivestim |
| Mdd US Operations, LLC | $41.18 | 2019 | |
| Acella Pharmaceuticals, LLC | $34.92 | 2025 | NP Thyroid 60 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.22 | 2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $32.18 | 2021 | |
| Averitas Pharma INC. | $29.15 | 2025 | Qutenza |
| Supernus Pharmaceuticals, INC. | $28.08 | 2021-2022 | |
| Shire North American Group INC | $22.89 | 2019 | |
| Acclarent, INC | $21.52 | 2023 | Acclarent Aera |
| Zyla Life Sciences, INC. | $20.30 | 2019 | |
| Genentech USA, INC. | $20.13 | 2020 | |
| Ironshore Pharmaceuticals INC. | $19.39 | 2023 | Jornay Pm |
| Noven Therapeutics, LLC | $18.60 | 2023 | Xelstrym |
| Inspire Medical Systems, INC. | $18.60 | 2024 | Inspire |
| Paratek Pharmaceuticals, INC. | $18.30 | 2024 | Nuzyra |
| Bardy Diagnostics, INC. | $18.24 | 2019-2020 | |
| Alkermes, INC. | $18.09 | 2025 | Lybalvi |
| Avanir Pharmaceuticals, INC. | $17.65 | 2019 | |
| Nabriva Therapeutics, Plc | $17.20 | 2020 | |
| Currax Pharmaceuticals LLC | $17.13 | 2021 | |
| Optos, INC. | $16.81 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Seqirus USA INC | $16.50 | 2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Medtronic USA, INC. | $16.03 | 2019 | |
| Piramal Critical Care | $15.84 | 2025 | |
| Adlon Therapeutics L.P. | $15.00 | 2021 | |
| Azurity Pharmaceuticals, INC. | $14.02 | 2023 | Edarbi |
| Orexo US, INC. | $13.13 | 2021 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Pucillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.